A number of stocks considered to be GLP-1 losers got hit after Dexcom. Unfortunately, seems like ResMed is still in that basket. In the previous earnings call ReaMed warned that the margin will come down a bit due to increased shipping costs, but if there a bigger drop and/or weak revenue, earnings or guidance the share price will be attacked hard. In other words anything but a perfect quarterly and the share price goes down.
A number of stocks considered to be GLP-1 losers got hit after...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$30.47 |
Change
-0.805(2.57%) |
Mkt cap ! $19.31B | |||
| Open | High | Low | Value | Volume |
| $30.37 | $30.63 | $30.12 | $56.50M | 1.848M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 2585 | $30.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $30.47 | 1414 | 13 |
View Market Depth
| Last trade - 14.14pm 29/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |